In CML patients, G0S2 expression was decreased in the CD34+ stem/progenitor cell compartment in blast phase CML (n = 5) compared to chronic phase patients (n = 6) [92]. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.